NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. £10 million (c. $13 million) financing round.

4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.

Warwick spinout Cytecom wins twice at Medilink Healthcare Business Awards

The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.